MX9203559A - Una forma de dosificacion para administrar clorofeniramina. - Google Patents

Una forma de dosificacion para administrar clorofeniramina.

Info

Publication number: MX9203559A
Authority: MX; Mexico
Prior art keywords: chloropheniramine; administering; dosage form; dosage; administering chloropheniramine
Prior art date: 1986-04-17

Application number

MX9203559A

Other languages

English (en)

Inventor

Sally I Stephens

Lawrence G Hamel

Glen E Barclay

Patrick S L Wong

Original Assignee

Alza Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-04-17

Filing date

1992-06-26

Publication date

1992-09-01

1992-06-26 Application filed by Alza Corp filed Critical Alza Corp

1992-09-01 Publication of MX9203559A publication Critical patent/MX9203559A/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

MX9203559A 1986-04-17 1992-06-26 Una forma de dosificacion para administrar clorofeniramina. MX9203559A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US85310986A	1986-04-17	1986-04-17
US07/176,561 US4857330A (en)	1986-04-17	1988-04-01	Chlorpheniramine therapy

Publications (1)

Publication Number	Publication Date
MX9203559A true MX9203559A (es)	1992-09-01

Family

ID=26872365

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX9203559A MX9203559A (es)	1986-04-17	1992-06-26	Una forma de dosificacion para administrar clorofeniramina.

Country Status (2)

Country	Link
US (1)	US4857330A (es)
MX (1)	MX9203559A (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8820353D0 (en) *	1988-08-26	1988-09-28	Staniforth J N	Controlled release tablet
DD295760A5 (de) *	1989-01-31	1991-11-14	Martin-Luther-Universitaet Halle Wittenberg,De	Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
US5698224A (en) *	1994-06-27	1997-12-16	Alza Corporation	Tacrine therapy
US5718700A (en) *	1994-09-20	1998-02-17	Alza Corporation	Exit means in dosage form
IL125658A0 (en) *	1997-08-18	1999-04-11	Hoffmann La Roche	Ccr-3 receptor antagonists
US6339087B1 (en) *	1997-08-18	2002-01-15	Syntex (U.S.A.) Llc	Cyclic amine derivatives-CCR-3 receptor antagonists
JP3421323B2 (ja)	1998-11-20	2003-06-30	エフ．ホフマン−ラロシュアーゲー	ピペリジンｃｃｒ−３受容体拮抗薬
AR026148A1 (es) *	2000-01-21	2003-01-29	Osmotica Argentina S A	Dispositivo osmotico con pasaje preformado que aumenta de tamano
US7838026B2 (en)	2001-09-28	2010-11-23	Mcneil-Ppc, Inc.	Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en)	2001-09-28	2006-10-17	Mcneil-Ppc, Inc.	Methods for manufacturing dosage forms
CA2461653A1 (en)	2001-09-28	2003-04-03	Mcneil-Ppc, Inc.	Edible composition and dosage form comprising an edible shell
MXPA06003150A (es) *	2003-09-17	2006-08-31	Johnson & Johnson	Compuestos heterociclicos fusionados.
US20060233882A1 (en) *	2005-04-15	2006-10-19	Sowden Harry S	Osmotic dosage form
US8673352B2 (en)	2005-04-15	2014-03-18	Mcneil-Ppc, Inc.	Modified release dosage form
US7598255B2 (en)	2005-08-04	2009-10-06	Janssen Pharmaceutica Nv	Pyrimidine compounds as serotonin receptor modulators
EP2010177A2 (en) *	2006-04-10	2009-01-07	Janssen Pharmaceutica N.V.	Combination histamine h1r and h4r antagonist therapy for treating pruritus
BR112012013676A2 (pt) *	2009-12-07	2016-04-19	Mcneil Ppc Inc	revestimento por imersão parcial de formas de dosagem para liberação modificada

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4014334A (en) *	1976-02-02	1977-03-29	Alza Corporation	Laminated osmotic system for dispensing beneficial agent
US4167558A (en) *	1976-02-13	1979-09-11	Hoffmann-La Roche Inc.	Novel sustained release tablet formulations
JPS57140710A (en) *	1981-02-24	1982-08-31	Shionogi & Co Ltd	Capsule agent for rectal administration
US4439195A (en) *	1980-10-14	1984-03-27	Alza Corporation	Theophylline therapy
US4439194A (en) *	1981-09-08	1984-03-27	Merck & Co., Inc.	Water and drug delivery system for suppository use
US4522625A (en) *	1982-09-29	1985-06-11	Alza Corporation	Drug dispenser comprising wall formed of semipermeable member and enteric member
US4576604A (en) *	1983-03-04	1986-03-18	Alza Corporation	Osmotic system with instant drug availability
US4631284A (en) *	1984-11-19	1986-12-23	Mallinckrodt, Inc.	Acetaminophen compositions containing low doses of chlorpheniramine maleate, method for preparing same and tablets formed therefrom

1988
- 1988-04-01 US US07/176,561 patent/US4857330A/en not_active Expired - Lifetime
1992
- 1992-06-26 MX MX9203559A patent/MX9203559A/es active IP Right Grant

Also Published As

Publication number	Publication date
US4857330A (en)	1989-08-15

Similar Documents

Publication	Publication Date	Title
MX9203560A (es)	1992-09-30	Una forma de dosis para surtir pseudoefedrina.
IT8723196A0 (it)	1987-12-23	Composizione farmaceutica a liberazione prolungata.
NO873999D0 (no)	1987-09-24	Dose-dispenser.
DE3780223D1 (de)	1992-08-13	Arzneimittel mit gesteuerter freisetzung.
FI882044A7 (fi)	1988-11-05	Hidastetun luovutuksen omaavat oraaliset antomuodot.
DE3778723D1 (de)	1992-06-11	Leicht absorbierbare pharmazeutische zubereitung.
DE59004551D1 (de)	1994-03-24	Tablettenspender.
FI863077L (fi)	1987-01-30	Farmaceutisk dosenhet.
MX9203559A (es)	1992-09-01	Una forma de dosificacion para administrar clorofeniramina.
NO882653D0 (no)	1988-06-15	Doseringsform.
DE68907177D1 (de)	1993-07-22	Dosierungsform.
DE3682960D1 (de)	1992-01-30	Pharmazeutische praeparate.
FI874382A0 (fi)	1987-10-06	Farmaceutiska preparat.
NO863625D0 (no)	1986-09-10	Medikamentdoseringsanordning.
FI881238A7 (fi)	1988-09-17	Farmaceutisk beredning.
MX9203782A (es)	1992-09-01	Forma de dosis con capacidad de administracion mejorada.
FI875616A0 (fi)	1987-12-21	Farmaceutiska blandningar.
ES509234A0 (es)	1982-12-16	Procedimiento para preparar una unidad de dosificacion parentepal farmaceutica.
DE58905160D1 (de)	1993-09-09	Pharmazeutische zubereitung.
NO882264D0 (no)	1988-05-24	Legemiddelpakning.
ES2023482B3 (es)	1992-01-16	Disolucion de humectacion para una presion-offset
DE3888800D1 (de)	1994-05-05	Transdermales Arzneimittelpräparat.
DE3667915D1 (de)	1990-02-08	Pharmazeutische zusammensetzung.
ATE90556T1 (de)	1993-07-15	Dosierungsform.
MX9203558A (es)	1992-07-01	Forma de dosis para administrar nicardipina antagonista de calcio.

Legal Events

Date	Code	Title	Description
1996-07-03	FG	Grant or registration